付録

Author guidelines: Volume 5 Issue 1

• 抽象的な

付録

Indices: Volume 5 Issue 1

• 抽象的な

付録

Glossary: Volume 5 Issue 1

• 抽象的な

付録

Bulletin board: Volume 5 Issue 1

• 抽象的な

付録

Acknowledgment: Volume 5 Issue 1

• 抽象的な

総説

Eating disorders related to obesity

Varsha Vaidya and Abdul Malik

• 抽象的な

総説

Hyperbaric oxygen therapy in the management of nonhealing wounds in patients with critical limb ischemia

Gunalp Uzun, Senol Yildiz and Samil Aktas

• 抽象的な

医薬品の評価

Recombinant human epoetin beta in the treatment of renal anemia

Lucia Del Vecchio Andrea Cavalli, Pietro Pozzoni and Francesco Locatelli

• 抽象的な

医薬品の評価

Vildagliptin: novel pharmacological approach to treat Type 2 diabetes

Bo Ahraain

• 抽象的な

総説

Osteoclast-targeted therapy for metastatic prostate cancer

Richard J Lee and Matthew R Smith

• 抽象的な

総説

Castrate-resistant prostate cancer: the right targets and combinations

Joyson Karakunnel and William Dahut

• 抽象的な

総説

New directions in endocrine therapy: renewed interest in the androgen receptor

Zoran Culig and Alfred Hobisch

• 抽象的な

総説

Salvage cryotherapy for recurrent prostate cancer after radiation failure: current status and future perspectives

Mohamed Ismail, Pandha Hardev and John Davies

• 抽象的な

視点

Avoiding surgery in prostate cancer patients with low-risk disease

Vladimir Mouraviev andThomas J Polascik

• 抽象的な

インタビュー

Dr Charles Drake speaks to Laura Dormer, Editor

Charles Drake

• 抽象的な

ニュースと見解

Focus on novel approaches in prostate cancer therapy

• 抽象的な

研究のハイライト

Highlights from the latest papers in prostate cancer research

Yaacov Richard Lawrence and Adam P Dicker

• 抽象的な

社説

TGF-β signaling dictates therapeutic targeting in prostate cancer

Natasha Kyprianou

• 抽象的な

社説

Therapeutic vaccines for prostate cancer: what have we learned?

James L Gulley

• 抽象的な

序文

Novel approaches for the treatment of prostate cancer

Philip M Arlen

• 抽象的な